Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC

BSE7441.40213.9 (+2.96 %)

PREV CLOSE ( ) 7227.50

OPEN PRICE ( ) 7242.35

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1525

TODAY'S LOW / HIGH ( )7091.90 7550.30

52 WK LOW / HIGH ( )4050.15 8139.85

NSE7410.30175.2 (+2.42 %)

PREV CLOSE( ) 7235.10

OPEN PRICE ( ) 7235.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 7410.30 (135)

VOLUME 21729

TODAY'S LOW / HIGH( ) 7057.00 7545.00

52 WK LOW / HIGH ( )4785 8139

Chairman	Shilpa Divekar Nirula
Managing Director	Sanjeev Kumar Panchal
Company Secretary	Manasa R
Director	Amita Bhave
Non Executive Director	Sylvia Lorena Varela Ramon Hooi-Bien Chuah Jesus Javier Diaz Ropero Esteso
Additional Director	Monica Widhani
Non Executive Independent Director	Revathy Ashok
Whole Time Director	Bhavana Agrawal

Incorporation Year : 11-07 1979

Registered Office :

Address : Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road Bengaluru,
Karnataka-560045 .

Phone : 080 6774 8000

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE